Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (271-280 of 501) with videos related to

Pageof 51
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin LymphomaRobert Chen, Joycelynne M Palmer, Peter Martin, et al.
Human Immunology|March 26, 2003
Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 allelesSimon F Lacey, Maria C Villacres, Corinna La Rosa, et al.
Cancer|November 18, 2020
Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor StudyMukta Arora, Yanjun Chen, Jessica Wu, et al.
Cancer Research|March 17, 2007
Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancyHarjeet Singh, Lisa Marie Serrano, Timothy Pfeiffer, et al.
Cancer Immunology Research|March 21, 2019
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory PhenotypeDarya Alizadeh, Robyn A Wong, Xin Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2022
Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor StudySaro H Armenian, Yanjun Chen, Lindsay Hageman, et al.
JAMA Oncology|June 3, 2016
Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor StudyMukta Arora, Can-Lan Sun, Kirsten K Ness, et al.
Transplantation and Cellular Therapy|June 13, 2024
Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) TherapyScott R Goldsmith, Geoffrey Shouse, F Lennie Wong, et al.
The Journal of Infectious Diseases|October 21, 2006
Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipientsSimon F Lacey, Corinna La Rosa, Wendy Zhou, et al.
Blood Advances|December 21, 2021
Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS reportNora Balas, Lindsey Hageman, Jessica Wu, et al.
Pageof 51

Showing results (271-280 of 501) with videos related to

Sort By:
Pageof 51
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin LymphomaRobert Chen, Joycelynne M Palmer, Peter Martin, et al.
Human Immunology|March 26, 2003
Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 allelesSimon F Lacey, Maria C Villacres, Corinna La Rosa, et al.
Cancer|November 18, 2020
Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor StudyMukta Arora, Yanjun Chen, Jessica Wu, et al.
Cancer Research|March 17, 2007
Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancyHarjeet Singh, Lisa Marie Serrano, Timothy Pfeiffer, et al.
Cancer Immunology Research|March 21, 2019
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory PhenotypeDarya Alizadeh, Robyn A Wong, Xin Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2022
Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor StudySaro H Armenian, Yanjun Chen, Lindsay Hageman, et al.
JAMA Oncology|June 3, 2016
Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor StudyMukta Arora, Can-Lan Sun, Kirsten K Ness, et al.
Transplantation and Cellular Therapy|June 13, 2024
Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) TherapyScott R Goldsmith, Geoffrey Shouse, F Lennie Wong, et al.
The Journal of Infectious Diseases|October 21, 2006
Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipientsSimon F Lacey, Corinna La Rosa, Wendy Zhou, et al.
Blood Advances|December 21, 2021
Conditioning intensity and probability of live birth after blood or marrow transplantation, a BMTSS reportNora Balas, Lindsey Hageman, Jessica Wu, et al.
Pageof 51